Liyun Yong

389 Xincun Rd
Xincun, 200065, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

C1orf112 promotes breast cancer growth by modulating the cell cycle.

C1orf112 promotes breast cancer growth by modulating the cell cycle.

Journal: Frontiers in bioengineering and biotechnology

Published: October 10, 2025

Logic-Gated HSV-TK/GCV Suicide Gene Circuit for Triple-Negative Breast Cancer.

Logic-Gated HSV-TK/GCV Suicide Gene Circuit for Triple-Negative Breast Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: August 04, 2025

Harnessing Oncolytic Viruses for Targeted Therapy in Triple-Negative Breast Cancer.

Harnessing Oncolytic Viruses for Targeted Therapy in Triple-Negative Breast Cancer.

Journal: International journal of medical sciences

Published: October 23, 2024

Unveiling the hidden role of SDHA in breast cancer proliferation: a novel therapeutic avenue.

Unveiling the hidden role of SDHA in breast cancer proliferation: a novel therapeutic avenue.

Journal: Cancer cell international

Published: January 17, 2024

Low expression of HIF1AN accompanied by less immune infiltration is associated with poor prognosis in breast cancer.

Low expression of HIF1AN accompanied by less immune infiltration is associated with poor prognosis in breast cancer.

Journal: Frontiers in oncology

Published: October 26, 2022

Long-term Survival After Diverse Therapeutic Modalities in Malignant Phyllodes Tumors of the Breast.

Long-term Survival After Diverse Therapeutic Modalities in Malignant Phyllodes Tumors of the Breast.

Journal: Technology in cancer research & treatment

Published: August 24, 2022

Reduced Expression of KRT17 Predicts Poor Prognosis in HER2high Breast Cancer.

Reduced Expression of KRT17 Predicts Poor Prognosis in HER2high Breast Cancer.

Journal: Biomolecules

Published: June 11, 2022

The role of hypoxia-inducible factor-1 alpha in multidrug-resistant breast cancer.

The role of hypoxia-inducible factor-1 alpha in multidrug-resistant breast cancer.

Journal: Frontiers in oncology

Published: June 09, 2022

CLEC10A can serve as a potential therapeutic target and its level correlates with immune infiltration in breast cancer.

CLEC10A can serve as a potential therapeutic target and its level correlates with immune infiltration in breast cancer.

Journal: Oncology letters

Published: February 21, 2022

Showing 1-9 of 9

Last Updated: 09/26/2026